Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Primer Shot Radiotherapy for Non-small Cell Lung Cancer - PRIMER

NCT06528743 is registered in ClinicalTrials.gov with The Netherlands Cancer Institute as lead sponsor.

NCT NCT06528743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06528743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Primer Shot Radiotherapy for Non-small Cell Lung Cancer - PRIMER
Lead sponsor
The Netherlands Cancer Institute
Phase
Not applicable
Overall status
Recruiting
Start date
August 8, 2024
Completion date
August 1, 2029
Enrollment
34 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients with non-small-cell lung cancer